Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ajanta Pharma has informed that it enclosed the schedule of Earnings Conference Call to be held on 30th July 2026, post Board meeting.
The above information is a part of company’s filings submitted to BSE.